MedTrace Logo

Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma

NCT00017160 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2013-06-27

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy, radiation therapy, and surgery may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy, radiation therapy, and surgery in treating patients who have primary or recurrent sarcoma.

Conditions

  • Stage III Adult Soft Tissue Sarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Stage IVA Adult Soft Tissue Sarcoma
  • Stage IIB Adult Soft Tissue Sarcoma
  • Stage IIC Adult Soft Tissue Sarcoma

Interventions

DRUG

doxorubicin

DRUG

filgrastim

DRUG

ifosfamide

PROCEDURE

biological response modifier therapy

PROCEDURE

brachytherapy

PROCEDURE

chemotherapy

PROCEDURE

colony-stimulating factor therapy

PROCEDURE

conventional surgery

PROCEDURE

cytokine therapy

PROCEDURE

intraoperative radiotherapy

PROCEDURE

radiation therapy

PROCEDURE

surgery

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Radiation Therapy Oncology Group

    lead NETWORK

Principal Investigators

  • Peter W. T. Pisters, MD · M.D. Anderson Cancer Center

Study Design

Purpose
TREATMENT

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00017160 on ClinicalTrials.gov